Skip to content
Screener

Phreesia PHR EV / EBITDA

EV / EBITDA at other companies

Veeva Systems logo
Veeva SystemsVEEV
15.8×-11.3×
OptimizeRx logo
OptimizeRxOPRX
6.6×—
Claritev Corporation logo
Claritev CorporationCTEV
10.9×-49.9×
InfuSystem Holdings logo
InfuSystem HoldingsINFU
8×+1.1×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
19×+3.3×
ExlService Holdings logo
ExlService HoldingsEXLS
10.9×-9.8×

Other financials

Income statement

See full
Revenue$130.9M+12.9%
Gross profit$113.3M+14.1%
Operating income$6.7M+305%
Net income$3.0M+176%
EPS (diluted)$0.05+171%

Balance sheet

See full
Cash & equivalents$73.8M-12.3%
Total debt$98.3M+242%
Total equity$359.1M+27.3%
Total assets$666.1M+66.4%

Cash flow

See full
Operating cash flow$23.9M+61.1%
CapEx$4.3M+23.0%
Free cash flow$19.6M+72.9%

Valuation

See full
Market cap$773.27M-52.1%
P/E84.2×—
P/S1.6×-2.0×

Profitability

See full
Gross margin85.4%+0.8pp
Operating margin0.7%+0.4pp
Net margin1.9%+1.0pp
FCF margin15.3%+6.9pp

Returns & leverage

See full
Return on equity2.9%+1.5pp
Debt / equity0.3×+0.2×
Current ratio1.8×-0.2×

Where this comes from

Calculated from Phreesia’s reported figures.

enterprise value/ebitda=17.3×

Based on the most recent quarter.

The source filing: Phreesia’s 10-Q, filed May 28, 2026. Open the filing →

Filed
May 28, 2026, 4:01 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001412408-26-000172

FAQ

What is Phreesia's EV / EBITDA?
Phreesia (PHR) reported EV / EBITDA of 17.3× in Q1 2026.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about Phreesia's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude